Synthesis and biological evaluation of Combretastatin A-4 derivatives containing a 3’-O-substituted carbonic ether moiety as potential antitumor agents

Chemistry Central Journal

Mingyi Ma¹  Longru Sun¹  Hongxiang Lou¹  Mei Ji¹ 

[1] Department of Natural Products Chemistry, Key Lab of Chemical Biology (MOE), School of Pharmaceutical Sciences, Shandong University, No. 44 West Wenhua Road, Jinan 250012, PR China

关键词: Apoptosis;    Cell cycle arrest;    WST-1;    Antitumor activity;    Synthesis;    Combretastatin A-4;   

Others  :  787815
DOI  :  10.1186/1752-153X-7-179

 received in 2013-08-21, accepted in 2013-11-25,  发布年份 2013

【 摘 要 】

Background

Combretastatin A-4 (CA-4), which is an excellent antineoplastic agent, was isolated from Combretum caffrum. To date, structural modification studies of CA-4 have focused predominantly on the construction of new therapeutic agents for drug discovery. As a part of our ongoing work towards the modification of natural products, we have focused on the 3’-O-substituent groups in the B-ring of CA-4 under the hypothesis that these novel derivatives will possess good bioactivities and behave as effective antiproliferative pro-drugs.

Results

A series of novel CA-4 derivatives, which contained a 3’-O-substituted carbonic ether moiety, were synthesized and evaluated for their antitumor activities against four tumor cell lines, including MDA-MB-231, MCF-7, K562 and A549 cells. These derivatives exhibited clear antitumor activities, and CA-4E, in particular, showed the highest bioactivity of all of the derivatives tested against all four tumor cell lines, with IC₅₀ values in the range of 1 to 180 nM. Based on its high bioactivity, CA-4E was subsequently selected to investigate the antitumor mechanism of these synthetic compounds. The cell cycle results demonstrated that CA-4E induced time- and dose-dependent G2/M arrest in a similar manner to CA-4, although its effect was more powerful than that of CA-4, and the apoptosis data showed that CA-4E induced cellular apoptosis in a dose-dependent manner.

Conclusions

The newly synthesized CA-4 derivatives exhibited good antitumor activities in vitro, with CA-4E, in particular, showing the highest bioactivity of all of the compounds tested. Furthermore, CA-4E induced time- and dose-dependent G2/M arrest and cellular apoptosis in a dose-dependent manner. Taken together, these results suggest that CA-4E should be subjected to further investigation as a potential anticancer drug candidate.

【 授权许可】

   
2013 Ma et al.; licensee Chemistry Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Scheme 1

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Pettit GR, Singh SB, Hamel E, Lin CM, Alberts DS, Garcia-Kendall D: Isolation and structure of the strong cell growth and tubulin inhibitor combretastatinA-4. Experientia 1989, 45:209-211.
• [2]Patterson DM, Rustin GJS: Vascular damaging agents. Clin Oncol 2007, 19:443-456.
• [3]Lippert JW III: Vascular disrupting agents. Bioorg Med Chem 2007, 15:605-615.
• [4]Hinnen P, Eskens F: Vascular disrupting agents in clinical development. Brit J Cancer 2007, 96:1159-1165.
• [5]Chang JY, Hsieh HP, Chang CY, Hsu KS, Chiang YF, Chen CM, Kuo CC, Liou JP: 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents. J Med Chem 2006, 49:6656-6659.
• [6]Lawrence NJ, Ghani FA, Hepworth LA, Hadfield JA, McGown AT, Pritchard RG: The synthesis of (E) and (Z)-combretastatins A-4 and a phenanthrene from Combretum caffrum. Synthesis 1999, 9:1656-1660.
• [7]Liou JP, Chang JY, Kuo FM, Chang CW, Tseng HY, Wang CC, Yang YN, Chang JY, Lee SJ, Hsieh HP: Concise synthesis and structure -activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. J Med Chem 2004, 47:4247-4257.
• [8]Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP: Synthesis and structure-activity relationships of 3-amino-benzophenones as antimitotic agents. J Med Chem 2004, 47:2897-2905.
• [9]Liou JP, Chang CW, Song JS, Yang YN, Yeh CF, Tseng HY, Lo YK, Chang YL, Chang CM, Hsieh HP: Synthesis and structure-activity relationship of 2-aminoben-zophenone derivatives as antimitotic agents. J Med Chem 2002, 45:2556-2562.
• [10]Woods JA, Hadfield JA, Pettit GR, Fox BW, McGown AT: The interaction with tubulin of a series of stilbenes based on combretastatinA-4. Brit J Cancer 1995, 71:705-711.
• [11]Lawrence NJ, Hepworth LA, Rennison D, McGown AT, Hadfield JA: Synthesis and anticancer activity of fluorinated analogues of combretastatin A-4. J Fluorine Chem 2003, 123:101-108.
• [12]Kong Y, Grembecka J, Edler MC, Hamel E, Mooberry SL, Sabat M, Rieger J, Brown ML: Structure-based discovery of a boronic acid bioisostere of combretastatin A-4. Chem Biol 2005, 12:1007-1014.
• [13]Pettit GR, Rhodes MR, Herald DL, Hamel E, Schmidt JM, Pettit RK: Antineoplastic agents: 445: synthesis and evaluation of structural modifications of (Z)-and (E)-combretastatin A-4. J Med Chem 2005, 48:4087-4099.
• [14]Chaplin DJ, Horsman MR, Siemann DW: Current development status of small-molecule vascular disrupting agents. Curr Opin Investig Drugs 2006, 7:522-528.
• [15]Kamal A, Mallareddy A, Ramaiah MJ, Pushpavalli SNCVL, Suresh P, Kishor C, Murty JNSRC, Rao NS, Ghosh S, Addlagatta A, Pal-Bhadra M: Synthesis and biological evaluation of combretastatin-amidobenzothiazole conjugates as potential anticancer agents. Eur J Med Chem 2012, 56:166-178.
• [16]Liu YQ, Li XJ, Zhao CY, Nan X, Tian J, Morris-Natschke SL, Zhang ZJ, Yang XM, Yang L, Li LH, Zhou XW, Lee KH: Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents. Bioorg Med Chem 2013, 21:1248-1256.
• [17]Pettit GR, Singh SB, Boyd MR, Hamel E, Pettit RK, Schmidt JM, Hogan F: Antineoplastic agents: 291: isolation and synthesis of combretastatins A-4, A-5, and A-6. J Med Chem 1995, 38:1666-1672.
• [18]Gaukroger K, Hadfield JA, Hepworth LA, Lawrence NJ, McGown AT: Novel syntheses of cis and trans isomers of combretastatin A-4. J Org Chem 2001, 66:8135-8138.
• [19]Ngamwongsatit P, Banada PP, Panbangred W, Bhunia AK: WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J Microbiol Meth 2008, 73:211-215.
• [20]Nandy P, Banerjee S, Gao H, Hui MBV, Lien EJ: Quantitative structure–activity relationship analysis of combretastatins: a class of novel antimitotic agents. Pharm Res 1991, 8:776-781.
• [21]Gambari R, Terada M, Bank A, Rifkind RA, Marks PA: Synthesis of globin mRNA in relation to the cell cycle during induced murine erythroleukemia differentiation. Proc Natl Acad Sci 1978, 75:3801-3804.